

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.34839764 |
| 2 | definitive hemopoiesis (GO:0060216) | 5.21049863 |
| 3 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.96417179 |
| 4 | positive regulation of B cell differentiation (GO:0045579) | 4.82653177 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.68431669 |
| 6 | nuclear pore complex assembly (GO:0051292) | 4.44437331 |
| 7 | energy homeostasis (GO:0097009) | 4.30773092 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.01093870 |
| 9 | imidazole-containing compound metabolic process (GO:0052803) | 3.90737166 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 3.88918566 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.88918566 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.88918566 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.88918566 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.88918566 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.88918566 |
| 16 | regulation of beta-amyloid formation (GO:1902003) | 3.88165026 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.65414670 |
| 18 | B cell receptor signaling pathway (GO:0050853) | 3.55805608 |
| 19 | histamine secretion (GO:0001821) | 3.55011705 |
| 20 | regulation of B cell differentiation (GO:0045577) | 3.51063781 |
| 21 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.50245831 |
| 22 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.44788390 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.38631772 |
| 24 | regulation of histone H3-K27 methylation (GO:0061085) | 3.36794026 |
| 25 | nuclear pore organization (GO:0006999) | 3.26672518 |
| 26 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.22507093 |
| 27 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.20599569 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.16811703 |
| 29 | response to muramyl dipeptide (GO:0032495) | 3.14776481 |
| 30 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.12870160 |
| 31 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.10188123 |
| 32 | zinc ion homeostasis (GO:0055069) | 3.06059847 |
| 33 | corticosteroid receptor signaling pathway (GO:0031958) | 3.05651303 |
| 34 | histone H3-K9 demethylation (GO:0033169) | 3.05002448 |
| 35 | pore complex assembly (GO:0046931) | 3.04957183 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04093298 |
| 37 | response to peptidoglycan (GO:0032494) | 3.03583298 |
| 38 | positive regulation of amino acid transport (GO:0051957) | 3.02270161 |
| 39 | histone demethylation (GO:0016577) | 3.01181162 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 2.99678903 |
| 41 | protein targeting to Golgi (GO:0000042) | 2.99664471 |
| 42 | histone lysine demethylation (GO:0070076) | 2.99638431 |
| 43 | establishment of protein localization to Golgi (GO:0072600) | 2.98170994 |
| 44 | regulation of erythrocyte differentiation (GO:0045646) | 2.95192236 |
| 45 | macrophage activation involved in immune response (GO:0002281) | 2.95048537 |
| 46 | positive regulation of granulocyte differentiation (GO:0030854) | 2.93105644 |
| 47 | histone H3-K36 demethylation (GO:0070544) | 2.92848464 |
| 48 | negative regulation of bone resorption (GO:0045779) | 2.87432132 |
| 49 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.86540897 |
| 50 | protein demethylation (GO:0006482) | 2.86337987 |
| 51 | protein dealkylation (GO:0008214) | 2.86337987 |
| 52 | myeloid cell development (GO:0061515) | 2.84672453 |
| 53 | regulation of B cell apoptotic process (GO:0002902) | 2.81819267 |
| 54 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.77706201 |
| 55 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.75163499 |
| 56 | regulation of cellular amide metabolic process (GO:0034248) | 2.74317812 |
| 57 | erythrocyte maturation (GO:0043249) | 2.74283072 |
| 58 | histamine transport (GO:0051608) | 2.72194216 |
| 59 | positive T cell selection (GO:0043368) | 2.71434176 |
| 60 | thymic T cell selection (GO:0045061) | 2.69778645 |
| 61 | granulocyte differentiation (GO:0030851) | 2.68567007 |
| 62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.67512771 |
| 63 | negative regulation of acute inflammatory response (GO:0002674) | 2.65654301 |
| 64 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.64745342 |
| 65 | DNA unwinding involved in DNA replication (GO:0006268) | 2.61616650 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 2.61051553 |
| 67 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.59893590 |
| 68 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.59879251 |
| 69 | negative thymic T cell selection (GO:0045060) | 2.58453892 |
| 70 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.56527597 |
| 71 | potassium ion export (GO:0071435) | 2.55419829 |
| 72 | neutrophil activation involved in immune response (GO:0002283) | 2.54610879 |
| 73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.53029363 |
| 74 | response to host immune response (GO:0052572) | 2.53029363 |
| 75 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.50869212 |
| 76 | negative regulation of cell killing (GO:0031342) | 2.50869212 |
| 77 | vitamin transmembrane transport (GO:0035461) | 2.50337085 |
| 78 | cellular extravasation (GO:0045123) | 2.48465731 |
| 79 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.47478823 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.46109105 |
| 81 | response to host (GO:0075136) | 2.46109105 |
| 82 | response to host defenses (GO:0052200) | 2.46109105 |
| 83 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.45759217 |
| 84 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.45201732 |
| 85 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.43950519 |
| 86 | T cell selection (GO:0045058) | 2.43471609 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.42424725 |
| 88 | megakaryocyte development (GO:0035855) | 2.41733830 |
| 89 | regulation of mast cell activation (GO:0033003) | 2.40082048 |
| 90 | regulation of necroptotic process (GO:0060544) | 2.39931301 |
| 91 | negative regulation of type 2 immune response (GO:0002829) | 2.39869349 |
| 92 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.39713726 |
| 93 | negative regulation of amino acid transport (GO:0051956) | 2.39333963 |
| 94 | leukocyte aggregation (GO:0070486) | 2.39050604 |
| 95 | oligosaccharide catabolic process (GO:0009313) | 2.38585505 |
| 96 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.37913160 |
| 97 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.37859442 |
| 98 | immunoglobulin mediated immune response (GO:0016064) | 2.36363072 |
| 99 | hyaluronan catabolic process (GO:0030214) | 2.36212840 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.35678520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.02530348 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.82950209 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.80441717 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.48309072 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.07658044 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.98533382 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.96955255 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.88103462 |
| 9 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.70079437 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.64170910 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.50689881 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.49907205 |
| 13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.42522790 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.31368296 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.30274916 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.26059041 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.23532295 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.18444520 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15765620 |
| 20 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.15536128 |
| 21 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.09887647 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09328697 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07107013 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06590797 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.05772473 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02584659 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01918755 |
| 28 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.98322254 |
| 29 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.98189935 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97983602 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.97966316 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93540776 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92525947 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90493903 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89201612 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.83077455 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.81276334 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78462867 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.72050893 |
| 40 | GATA1_19941826_ChIP-Seq_K562_Human | 1.71721863 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.71550957 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69091061 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68525891 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63256727 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62639988 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58055676 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.57725698 |
| 48 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.56940488 |
| 49 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.56397544 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50603234 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48997095 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47537100 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44197316 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43612174 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.42858012 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42822352 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42251222 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40630927 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39787906 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37627585 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36971498 |
| 62 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.34562725 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33968258 |
| 64 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32066615 |
| 65 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31968373 |
| 66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.31068996 |
| 67 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.28853731 |
| 68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.28767102 |
| 69 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.26908734 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.26559656 |
| 71 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25755683 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25664139 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25458149 |
| 74 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.22796122 |
| 75 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18940542 |
| 76 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18570954 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15581994 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13409878 |
| 79 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12520433 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12505593 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10754949 |
| 82 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.10299037 |
| 83 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06884845 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06550131 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06469782 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.05540695 |
| 87 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.03101500 |
| 88 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00271570 |
| 89 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00143243 |
| 90 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.99565864 |
| 91 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99466437 |
| 92 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.97885760 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97361858 |
| 94 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.97061028 |
| 95 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93663884 |
| 96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.93367001 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93020789 |
| 98 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90477152 |
| 99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90009259 |
| 100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89171901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001545_abnormal_hematopoietic_system | 3.68526153 |
| 2 | MP0005397_hematopoietic_system_phenotyp | 3.68526153 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 3.44869345 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.17677012 |
| 5 | MP0005451_abnormal_body_composition | 3.07408085 |
| 6 | MP0009278_abnormal_bone_marrow | 3.04174536 |
| 7 | MP0003763_abnormal_thymus_physiology | 3.04053276 |
| 8 | MP0008057_abnormal_DNA_replication | 2.59658242 |
| 9 | MP0003436_decreased_susceptibility_to | 2.59012321 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.54921025 |
| 11 | MP0004808_abnormal_hematopoietic_stem | 2.53503062 |
| 12 | MP0002822_catalepsy | 2.53389618 |
| 13 | MP0002009_preneoplasia | 2.52306599 |
| 14 | MP0000372_irregular_coat_pigmentation | 2.46919857 |
| 15 | MP0008961_abnormal_basal_metabolism | 2.29796653 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.12920341 |
| 17 | MP0002132_abnormal_respiratory_system | 2.02905308 |
| 18 | MP0005409_darkened_coat_color | 1.97394396 |
| 19 | MP0002166_altered_tumor_susceptibility | 1.95328180 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.91250222 |
| 21 | MP0002398_abnormal_bone_marrow | 1.80482436 |
| 22 | MP0003303_peritoneal_inflammation | 1.75614393 |
| 23 | MP0000703_abnormal_thymus_morphology | 1.66724476 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.61820912 |
| 25 | MP0002722_abnormal_immune_system | 1.60807676 |
| 26 | MP0008260_abnormal_autophagy | 1.60725652 |
| 27 | MP0002419_abnormal_innate_immunity | 1.60137068 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.57996595 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.57082925 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.55101643 |
| 31 | MP0001800_abnormal_humoral_immune | 1.54504922 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.54138794 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.51950047 |
| 34 | MP0001819_abnormal_immune_cell | 1.51818767 |
| 35 | MP0002723_abnormal_immune_serum | 1.50096844 |
| 36 | MP0000716_abnormal_immune_system | 1.45554746 |
| 37 | MP0010094_abnormal_chromosome_stability | 1.45167873 |
| 38 | MP0009697_abnormal_copulation | 1.41881850 |
| 39 | MP0000015_abnormal_ear_pigmentation | 1.39662658 |
| 40 | MP0002429_abnormal_blood_cell | 1.37905118 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.37583099 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.36690152 |
| 43 | MP0005025_abnormal_response_to | 1.34527944 |
| 44 | MP0002405_respiratory_system_inflammati | 1.33922063 |
| 45 | MP0004381_abnormal_hair_follicle | 1.29250954 |
| 46 | MP0004947_skin_inflammation | 1.24951357 |
| 47 | MP0000685_abnormal_immune_system | 1.23447125 |
| 48 | MP0009840_abnormal_foam_cell | 1.20612944 |
| 49 | MP0001873_stomach_inflammation | 1.20442904 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.18240552 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.18168459 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.17545712 |
| 53 | MP0005379_endocrine/exocrine_gland_phen | 1.16232687 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.15720717 |
| 55 | MP0003943_abnormal_hepatobiliary_system | 1.13194384 |
| 56 | MP0002006_tumorigenesis | 1.10555351 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.08009275 |
| 58 | MP0004233_abnormal_muscle_weight | 1.06541563 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.06006150 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.03592225 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.01701488 |
| 62 | MP0001790_abnormal_immune_system | 0.99367781 |
| 63 | MP0005387_immune_system_phenotype | 0.99367781 |
| 64 | MP0009765_abnormal_xenobiotic_induced | 0.97785964 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 0.96008293 |
| 66 | MP0002019_abnormal_tumor_incidence | 0.94570878 |
| 67 | MP0003077_abnormal_cell_cycle | 0.93102648 |
| 68 | MP0005375_adipose_tissue_phenotype | 0.92616118 |
| 69 | MP0005083_abnormal_biliary_tract | 0.91236425 |
| 70 | MP0005410_abnormal_fertilization | 0.90415409 |
| 71 | MP0000678_abnormal_parathyroid_gland | 0.89993159 |
| 72 | MP0008995_early_reproductive_senescence | 0.89831778 |
| 73 | MP0005671_abnormal_response_to | 0.88703675 |
| 74 | MP0002970_abnormal_white_adipose | 0.88268282 |
| 75 | MP0001851_eye_inflammation | 0.87698671 |
| 76 | MP0009115_abnormal_fat_cell | 0.86810962 |
| 77 | MP0001533_abnormal_skeleton_physiology | 0.84567652 |
| 78 | MP0009785_altered_susceptibility_to | 0.83891151 |
| 79 | MP0001845_abnormal_inflammatory_respons | 0.83449613 |
| 80 | MP0000490_abnormal_crypts_of | 0.83084672 |
| 81 | MP0003111_abnormal_nucleus_morphology | 0.82665052 |
| 82 | MP0005266_abnormal_metabolism | 0.82055533 |
| 83 | MP0009931_abnormal_skin_appearance | 0.80648755 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.79562578 |
| 85 | MP0003724_increased_susceptibility_to | 0.79427239 |
| 86 | MP0001727_abnormal_embryo_implantation | 0.77567933 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.77476506 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.76473282 |
| 89 | MP0010155_abnormal_intestine_physiology | 0.75235449 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.74351033 |
| 91 | MP0009764_decreased_sensitivity_to | 0.73642219 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.73224151 |
| 93 | MP0003786_premature_aging | 0.72058234 |
| 94 | MP0000350_abnormal_cell_proliferation | 0.70877988 |
| 95 | MP0000598_abnormal_liver_morphology | 0.69374866 |
| 96 | MP0008007_abnormal_cellular_replicative | 0.68445097 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 0.68079304 |
| 98 | MP0008469_abnormal_protein_level | 0.66586478 |
| 99 | MP0001348_abnormal_lacrimal_gland | 0.66271895 |
| 100 | MP0000609_abnormal_liver_physiology | 0.65974475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute lymphatic leukemia (HP:0006721) | 5.32489331 |
| 2 | Stomatitis (HP:0010280) | 4.63059861 |
| 3 | Fatigue (HP:0012378) | 4.58869988 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.44178232 |
| 5 | Menstrual irregularities (HP:0000858) | 3.97722723 |
| 6 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.93909927 |
| 7 | Abnormality of the fingertips (HP:0001211) | 3.92346236 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.14757914 |
| 9 | Abnormality of the thoracic spine (HP:0100711) | 3.06926008 |
| 10 | Thrombocytosis (HP:0001894) | 3.06667104 |
| 11 | Progressive muscle weakness (HP:0003323) | 3.00306923 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 2.97834909 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.96938117 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.96938117 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 2.96938117 |
| 16 | Prominent nose (HP:0000448) | 2.94192765 |
| 17 | Recurrent viral infections (HP:0004429) | 2.91177285 |
| 18 | Thoracic kyphosis (HP:0002942) | 2.88570248 |
| 19 | Reticulocytosis (HP:0001923) | 2.88471794 |
| 20 | Recurrent abscess formation (HP:0002722) | 2.82330921 |
| 21 | Prostate neoplasm (HP:0100787) | 2.78966684 |
| 22 | Polycythemia (HP:0001901) | 2.78110790 |
| 23 | Prolonged bleeding time (HP:0003010) | 2.74504543 |
| 24 | Peripheral hypomyelination (HP:0007182) | 2.63262467 |
| 25 | Increased serum ferritin (HP:0003281) | 2.54821735 |
| 26 | Abnormality of iron homeostasis (HP:0011031) | 2.54308176 |
| 27 | Viral hepatitis (HP:0006562) | 2.49852180 |
| 28 | Acute hepatic failure (HP:0006554) | 2.46790613 |
| 29 | Abnormality of the right ventricle (HP:0001707) | 2.45185074 |
| 30 | Hepatitis (HP:0012115) | 2.41667249 |
| 31 | Asymmetry of the thorax (HP:0001555) | 2.38511011 |
| 32 | Abnormality of the prostate (HP:0008775) | 2.33843814 |
| 33 | Abnormality of the sella turcica (HP:0002679) | 2.33006614 |
| 34 | Stomach cancer (HP:0012126) | 2.29313815 |
| 35 | Petechiae (HP:0000967) | 2.28288589 |
| 36 | Arterial thrombosis (HP:0004420) | 2.27505339 |
| 37 | Tubulointerstitial nephritis (HP:0001970) | 2.26711791 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.26333699 |
| 39 | Neurodegeneration (HP:0002180) | 2.24684792 |
| 40 | Truncal obesity (HP:0001956) | 2.20036593 |
| 41 | Cutaneous melanoma (HP:0012056) | 2.19417320 |
| 42 | Poikilocytosis (HP:0004447) | 2.18118095 |
| 43 | Acute myeloid leukemia (HP:0004808) | 2.17836843 |
| 44 | Cellulitis (HP:0100658) | 2.17480677 |
| 45 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.16089364 |
| 46 | Increased IgE level (HP:0003212) | 2.12747991 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.10845708 |
| 48 | Abnormality of the columella (HP:0009929) | 2.08783770 |
| 49 | Epistaxis (HP:0000421) | 2.07942270 |
| 50 | Deformed sella turcica (HP:0002681) | 2.07056893 |
| 51 | Granulocytopenia (HP:0001913) | 2.05739684 |
| 52 | Abnormality of homocysteine metabolism (HP:0010919) | 2.02401914 |
| 53 | Homocystinuria (HP:0002156) | 2.02401914 |
| 54 | Eczematoid dermatitis (HP:0000976) | 2.01979054 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01805229 |
| 56 | Mucopolysacchariduria (HP:0008155) | 2.01805229 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98250569 |
| 58 | Abnormality of macrophages (HP:0004311) | 1.97879170 |
| 59 | Abnormality of male internal genitalia (HP:0000022) | 1.96463303 |
| 60 | Dysmetric saccades (HP:0000641) | 1.95614972 |
| 61 | Chest pain (HP:0100749) | 1.95289950 |
| 62 | Somatic mutation (HP:0001428) | 1.94046212 |
| 63 | Recurrent skin infections (HP:0001581) | 1.93133455 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 1.91754098 |
| 65 | Abnormality of the lumbar spine (HP:0100712) | 1.89309416 |
| 66 | T lymphocytopenia (HP:0005403) | 1.89175566 |
| 67 | Colitis (HP:0002583) | 1.89041994 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.87839641 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.87839641 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.87839641 |
| 71 | B lymphocytopenia (HP:0010976) | 1.86845525 |
| 72 | Gingival bleeding (HP:0000225) | 1.84340442 |
| 73 | Gingivitis (HP:0000230) | 1.83225196 |
| 74 | Meningitis (HP:0001287) | 1.81722957 |
| 75 | Episodic fever (HP:0001954) | 1.81522559 |
| 76 | Encephalitis (HP:0002383) | 1.80546539 |
| 77 | Chronic otitis media (HP:0000389) | 1.79879982 |
| 78 | Abnormality of methionine metabolism (HP:0010901) | 1.79448968 |
| 79 | Myelodysplasia (HP:0002863) | 1.79122329 |
| 80 | Inflammation of the large intestine (HP:0002037) | 1.79100272 |
| 81 | Sandal gap (HP:0001852) | 1.78569137 |
| 82 | Narrow palate (HP:0000189) | 1.76708687 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 1.74790593 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 1.74557693 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 1.73033997 |
| 86 | Glucose intolerance (HP:0000833) | 1.71707715 |
| 87 | Abnormality of B cell number (HP:0010975) | 1.71510886 |
| 88 | Obstructive lung disease (HP:0006536) | 1.70749472 |
| 89 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70749472 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 1.70187669 |
| 91 | Abnormality of T cells (HP:0002843) | 1.69689743 |
| 92 | Metaphyseal dysplasia (HP:0100255) | 1.68798471 |
| 93 | Stridor (HP:0010307) | 1.68059371 |
| 94 | Abnormality of lateral ventricle (HP:0030047) | 1.66938979 |
| 95 | Abnormal hair whorl (HP:0010721) | 1.66035133 |
| 96 | Abnormality of T cell number (HP:0011839) | 1.65818865 |
| 97 | Progressive external ophthalmoplegia (HP:0000590) | 1.65586923 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 1.64782346 |
| 99 | Osteomyelitis (HP:0002754) | 1.64514174 |
| 100 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.64159189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 4.40534493 |
| 2 | NME2 | 4.40457784 |
| 3 | SCYL2 | 3.32025468 |
| 4 | CDK12 | 3.26387856 |
| 5 | BRD4 | 2.98472237 |
| 6 | MAP4K1 | 2.84617323 |
| 7 | MAP2K3 | 2.43644823 |
| 8 | RIPK4 | 2.21319426 |
| 9 | FRK | 1.88071294 |
| 10 | PLK4 | 1.86804968 |
| 11 | MAP3K6 | 1.76967731 |
| 12 | SIK2 | 1.76040537 |
| 13 | GRK6 | 1.71770514 |
| 14 | CDK3 | 1.63527617 |
| 15 | BTK | 1.56999023 |
| 16 | TRIB3 | 1.54985729 |
| 17 | MARK3 | 1.53720895 |
| 18 | RPS6KA4 | 1.44232368 |
| 19 | MAP3K10 | 1.42198783 |
| 20 | MAP3K1 | 1.38612493 |
| 21 | ZAP70 | 1.35909320 |
| 22 | ERN1 | 1.28141774 |
| 23 | IRAK4 | 1.27014982 |
| 24 | SIK3 | 1.24303327 |
| 25 | SIK1 | 1.23684456 |
| 26 | FGFR3 | 1.23211484 |
| 27 | IRAK1 | 1.21890879 |
| 28 | MAP2K6 | 1.21550604 |
| 29 | TNK2 | 1.19625413 |
| 30 | FGFR2 | 1.18499131 |
| 31 | MAP3K14 | 1.18368744 |
| 32 | SYK | 1.16288100 |
| 33 | MAPK11 | 1.15923446 |
| 34 | PTK2B | 1.14507110 |
| 35 | IKBKE | 1.14044944 |
| 36 | TAOK2 | 1.09746417 |
| 37 | ICK | 1.08066849 |
| 38 | TEC | 1.07435920 |
| 39 | HCK | 1.04883076 |
| 40 | JAK3 | 1.04837840 |
| 41 | EEF2K | 1.02580072 |
| 42 | PDK1 | 1.01942403 |
| 43 | MAP3K2 | 1.01620781 |
| 44 | PIM1 | 1.01348015 |
| 45 | BLK | 0.97570269 |
| 46 | TRPM7 | 0.96248049 |
| 47 | MAP3K5 | 0.94905324 |
| 48 | HIPK2 | 0.94371474 |
| 49 | PDPK1 | 0.93641171 |
| 50 | MAP3K3 | 0.93121214 |
| 51 | JAK1 | 0.91892600 |
| 52 | PASK | 0.91710963 |
| 53 | CDK4 | 0.91610168 |
| 54 | TAOK3 | 0.90459756 |
| 55 | MELK | 0.87858263 |
| 56 | MARK2 | 0.84643878 |
| 57 | MTOR | 0.84567918 |
| 58 | IRAK3 | 0.84142855 |
| 59 | ITK | 0.82174705 |
| 60 | EPHB1 | 0.81827642 |
| 61 | NEK9 | 0.80798062 |
| 62 | TXK | 0.78240884 |
| 63 | CDK8 | 0.75837043 |
| 64 | CDK7 | 0.72396469 |
| 65 | JAK2 | 0.72282447 |
| 66 | MAP3K11 | 0.71319970 |
| 67 | EIF2AK1 | 0.70842092 |
| 68 | SMG1 | 0.70532282 |
| 69 | FES | 0.68818765 |
| 70 | TBK1 | 0.68790305 |
| 71 | CSNK1G3 | 0.68285969 |
| 72 | MAP2K4 | 0.67998550 |
| 73 | BCKDK | 0.65669247 |
| 74 | PIK3CG | 0.65663988 |
| 75 | MAP2K7 | 0.65221274 |
| 76 | LCK | 0.63722326 |
| 77 | IRAK2 | 0.63583106 |
| 78 | CAMK1D | 0.60018654 |
| 79 | LYN | 0.58696244 |
| 80 | IKBKB | 0.57692598 |
| 81 | PRKAA2 | 0.56614321 |
| 82 | CHEK1 | 0.53403882 |
| 83 | TYK2 | 0.52835991 |
| 84 | NEK2 | 0.52784752 |
| 85 | RET | 0.48040099 |
| 86 | CHUK | 0.48001815 |
| 87 | STK10 | 0.47577712 |
| 88 | CAMK1G | 0.47033783 |
| 89 | PRKCQ | 0.46818433 |
| 90 | STK38 | 0.45795483 |
| 91 | CDC7 | 0.45198600 |
| 92 | BMPR2 | 0.43325785 |
| 93 | RAF1 | 0.43045398 |
| 94 | PIM2 | 0.42568241 |
| 95 | RPS6KB1 | 0.41849074 |
| 96 | SGK3 | 0.38987605 |
| 97 | CDK9 | 0.38614781 |
| 98 | ATR | 0.37980842 |
| 99 | NEK6 | 0.37810698 |
| 100 | AKT1 | 0.37372133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.96934552 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.56523351 |
| 3 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.40826816 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.35318536 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.09088757 |
| 6 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.06581609 |
| 7 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.91937817 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.91370083 |
| 9 | Hepatitis B_Homo sapiens_hsa05161 | 1.79049080 |
| 10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.78104070 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66936064 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61252761 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60998122 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.53305899 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45727755 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40809283 |
| 17 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.37265215 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34278451 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31639643 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.30264784 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29672778 |
| 22 | Lysine degradation_Homo sapiens_hsa00310 | 1.29221135 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28088565 |
| 24 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.26879114 |
| 25 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.25772444 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.25539283 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.24665701 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.24054904 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23793376 |
| 30 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.21707950 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21529796 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20438156 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15860457 |
| 34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.13871252 |
| 35 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.12876275 |
| 36 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.12553220 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.11453608 |
| 38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.06764045 |
| 39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05677626 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.03318175 |
| 41 | Glioma_Homo sapiens_hsa05214 | 1.01487352 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99050623 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97899490 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.96654668 |
| 45 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.95280057 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 0.95230688 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95205389 |
| 48 | Prostate cancer_Homo sapiens_hsa05215 | 0.94820051 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 0.94172306 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92486659 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91321376 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91306165 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.91103836 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90467892 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.89911140 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87945472 |
| 57 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.85924944 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83941359 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 0.82685650 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81533638 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81174405 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80711124 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80650926 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80582028 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80038453 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79637441 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78348535 |
| 68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77692825 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.77437232 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.77063527 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76561885 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74472554 |
| 73 | Malaria_Homo sapiens_hsa05144 | 0.72389151 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 0.71950446 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71484361 |
| 76 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.68421520 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67176424 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66992323 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66022083 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65600903 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63815224 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63679233 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61608721 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61530314 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.60652512 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60635602 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59743749 |
| 88 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.59218523 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58672150 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58253521 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58222442 |
| 92 | RNA transport_Homo sapiens_hsa03013 | 0.57783310 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57192470 |
| 94 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57085978 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.55057044 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54297072 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54210798 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54049066 |
| 99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53705884 |
| 100 | Base excision repair_Homo sapiens_hsa03410 | 0.53705521 |

